Injecting drug use and infections. Vivian Hope IDU Team, HIV & STI Department, Health Protection...
Transcript of Injecting drug use and infections. Vivian Hope IDU Team, HIV & STI Department, Health Protection...
Injecting drug use and infections.
Vivian HopeIDU Team, HIV & STI Department, Health Protection Services – Colindale
Dr Vivian Hope, Dr Fortune Ncube & Katelyn CullenInjecting Drug Use Team, HIV & STI Department,
Centre for Infectious Disease Surveillance and Control,
Public Health England.
Part 1
BBV and bacterial infections among people who inject psychoactive drug injectors
UAM Survey of People Who Inject Drugs (PWID)
Started in England & Wales in 1990 as a response to the HIV epidemic ( + Northern Ireland since 2002).
Uses the Voluntary Unlinked & Anonymous method.
Recruits PWID through sentinel collaborating drug services (e.g. needle & syringe programmes (NSPs); maintenance & prescribing programmes; etc.).
Involves collaborating services in approximately 45 English DATs each year (recruiting in about 60 locations).
Recruits participants (current & former injectors) to provide a biological sample and self-complete a brief questionnaire.
Survey Aims to:1. measure the prevalence of HIV and viral hepatitis in PWID.2. monitor changes in related behaviours.
HIV prevalence among PWID, England & Wales.
Data source: UAM Survey of PWID.
Hepatitis C and Hepatitis B prevalence among PWID, England & Wales.
Data source: UAM Survey of PWID.
0.1
.2.3
.4.5
.6.7
HC
V
0.0
2.0
4.0
6.0
8H
IV
1980 1985 1990 1995 2000 2005 2010Year
1st year injecting
0.1
.2.3
.4.5
.6.7
HC
V
0.0
2.0
4.0
6.0
8H
IV1980 1985 1990 1995 2000 2005 2010
Year
7 years injectingLondon
0.1
.2.3
.4.5
HC
V
0.0
05.0
1.0
15.0
2.0
25H
IV
1980 1985 1990 1995 2000 2005 2010Year
1st year injecting
0.1
.2.3
.4.5
HC
V
0.0
05.0
1.0
15.0
2.0
25H
IV
1980 1985 1990 1995 2000 2005 2010Year
7 years injectingRest of E&W
Estimated HIV & HCV incidence among PWID, England & Wales.
Data source: UAM Survey of PWID.Incidence modelled in a Bayesian framework using prevalence by time since first injection jointly for HIV and hepatitis C. Hope et al, Forthcoming.
Spore forming bacterial infections among PWID: UK
0
10
20
30
40
50
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Nu
mb
er o
f ca
ses
Reported cases of Wound Botulism Reported cases of Tetanus Reported cases of Anthrax
Now - 1
Current HIV prevalence probably stable – at around 1.0% to 1.5%.
Current HIV incidence less clear, but also probably stable.
Majority (~80%) of PWID living with HIV are aware of their infection.
Hepatitis C prevalence – probably stable – but only half aware of their infection.
Around 1 in 17 are infected with hepatitis C for the first time each year.
Uptake of Voluntary Confidential testing for hepatitis C & proportion aware of their status: England
Data source: UAM Survey of PWID.
Now - 2
Hepatitis B – ever infection declining – mainly due to vaccination.
Very few with current hepatitis B infection (<1%).
Spore forming bacteria – so far in 2013, two probable tetanus cases, but no cases of anthrax or wound botulism among PWID.
Proportion reporting a ‘sore’ at injection site during the last year may be declining (28%, down from 38% in 2007).
Hepatitis B vaccine uptake: England
Data source: UAM Survey of PWID.
Sharing of injecting equipment has been declining.
Trends in sharing among current* PWID in England, Wales & NI: 2000-2011
* Those who had last injected in the four weeks preceding participation in the survey. Data source: UAM Survey of PWID.
Coverage of Needle and Syringe Programmes (NSP).
NSP are providing sterile injecting equipment throughout the UK.
• In England, an indirect measure of NSP coverage indicated that for 57% of PWID surveyed, the number of needles received from NSP was greater than the number of times they had injected.
• In Scotland, during 2009/10 approximately 4.7 million needles/syringes were distributed by 255 sites (up from 3.6 million by 188 sites in 2004/05). Estimated number distributed to each PWID during 2009/10 was approximately 200, less than the estimated average of 465 injections per year.
• In Wales, there were 247 NSP sites operating in 2011, which distributed 5,140,219 needles/syringes.
• In Northern Ireland, the number of packs dispensed by NSP increased to 25,530 in 2011/12; this is around 10,000 more than in 2007/08.
These data show that NSP provision in the UK is extensive, and that provision has increased. However, they also indicate a need to further increase the amount of equipment distributed.
Risks
Indicators of risk
Among those who injected in the last month: -
Injected with cleaned works 32%
Injected crack-cocaine 32%
Injected into groin 35%
Had sex last year 73%
Men reporting male partner(s) in last year 5%
Ever homeless In last year
77%28%
Ever imprisoned (Data from 2010 suggest 1 in 5 imprisoned during preceding year year)
71%
Data source: UAM Survey of PWID.
Factors associated with recent hepatitis C infection
N
Recent Infection
Adjusted Odd Ratios (OR)
n % OR 95% CI
GenderMale 750 12 1.6% 1.0
Female 230 8 3.5% 3.8 1.4- 10
Anti-HBcDetected 56 5 8.9% 6.3 2.1- 18
Not detected 924 15 1.6% 1.0
Had ever been to prison
No 362 3 0.8% 1.0
Yes, 1-4 times 405 9 2.2% 3.7 0.95- 14
Yes, >=5 times 213 8 3.8% 8.7 2.0- 37
Cullen et al. Forthcoming
Forthcoming Data & Reports
Dates to be confirmed:-
•UAM Survey of PWID annual data tables (data to end of 2012) - around 19 July.
•Hepatitis C in the UK report - around 25 July.
•‘Shooting Up’ report - early November – proposed focus this year is on the possible impacts of the changing patterns of injecting drug use on infections.
•HIV in the UK report - late November.
Part 2
Injecting is changing
IPEDs are used to change physical appearance or improve performance / strength.
This sub-group of people who inject drugs (PWID) is rarely studied.
Anabolic steroids (AS) are probably the most commonly used type of IPED.
Drug (2011/12)Last year
Ever
Anabolic steroids 70,000 228,000
Heroin 47,000 255,000
‘All’ & ‘new’ clients attending agency based Needle and Syringe Programmes (NSPs) in
Cheshire & Merseyside: 1991-2011.
Image and Performance Enhancing Drug (IPED) Injecting
British Crime Survey, 2012
IPED injection and risk
A wide range IPED are used and injected. The Anabolic Steroids are the mostly commonly used and injected, but there is a wide range of others.
A recent study of 395 male IPED injectors (undertake by PHE with LJMU & Public Health Wales) found:-
IPEDs injected: Anabolic steroids (86%); growth hormone (32%); hCG (16%); Insulin (6%); Melanotan I/II (9%).
IPED taken orally: Anabolic steroids (57%); Anti–oestrogens (23%); Clenbuterol (15%); Ephedrine (20%); Phosphodiesterase type 5 inhibitors ("Viagra /Cialis“, 7%).
Overall, 9% had ever shared injecting equipment.
High levels of sexual activity, condom use poor; 3% had sex with a man in the past year.
High levels of non-injecting psychoactive drug use in past year: 46% cocaine, 12% amphetamine. 5% had ever injected a psychoactive drug.
Hope et al. Forthcoming
5.5%
8.8%
1.5%
0%
5%
10%
15%
Anti-HCVpositive*
Anti-HBcpositive*
Anti-HIVpositive
Pre
vale
nce
*Adjusted to test sensitivity
Markers of BBV infectionNote: Oral Fluid sample test sensitivity for anti-HBc is 75% and anti-HCV
92%.
Among the male injectors of psychoactive drugs taking part in the UAM Survey in 2011:
45% (95%CI 43%-48%) had anti-HCV;
16% (95%CI 14% -18%) had anti-HBc;
1.4% (95% CI 0.88% -2.2%) had anti-HIV.
Hope et al. HIV Medicine 2013, & Forthcoming
New Psychoactive Drugs
These are mostly not injected. However, there is increasing concern about the injection of these – particularly Mephedrone (M-Cat) and Ketamine.
Injecting Ketamine not new, but this had been ‘rare’ – but the numbers may be increasing.
First reports of Mephedrone injection in the UK in ~2011 – currently appears to be localised in a few areas.
Injecting synthetic cathinones –like Mephedrone – associated with recent HIV outbreak in Romania.
Injecting drug use among MSM
There have recently been concerns about the changing patterns of drug use among some sub-groups of MSM.
Particularly the use of new psychoactive drugs and the increased use of methamphetamine.
Injecting relatively rare among gay and bisexual identified men.
There is emerging evidence of a small number of MSM – mostly HIV positive gay identified men – ‘slamming’ (injecting methamphetamine) often in the context of ‘sex parties’. Concerns about transmission of STIs and hepatitis C.